ABOUT ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURERS

These carryover should not lead to the carryover of degradants or microbial contamination which will adversely change the established API impurity profile.Products really should be created to ensure surfaces that contact raw materials, intermediates, or APIs don't change the caliber of the intermediates and APIs past the Formal or other set up spec